featured
Finerenone Reduces Cardiovascular Events in Patients With Chronic Kidney Disease and Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Circulation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes
Circulation 2020 Nov 16;[EPub Ahead of Print], G Filippatos, SD Anker, R Agarwal, B Pitt, LM Ruilope, P Rossing, P Kolkhof, P Schloemer, I Tornus, A Joseph, GL BakrisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.